Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 USD | -2.33% | -7.38% | -64.85% |
Evolution of the average Target Price on NovaBay Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering NovaBay Pharmaceuticals, Inc.
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- NBY Stock
- Consensus NovaBay Pharmaceuticals, Inc.